Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. COO
2. ORCL
3. CHWY
4. AVAV
5. SPY
6. META
7. NVDA
8. MSFT
9. ASO
10. AAPL

Go back to Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.75 -1.84 (3.04%)
Previous Close $60.59    52 Week High $3.48 
Open $60.44    52 Week Low $0.80 
Day High $60.71    P/E N/A 
Day Low $58.64    EPS $-1.54 
Volume 3,324,562       

(NASDAQ: ZYME) Delayed: 26.44 -0.71 (2.62%)
Previous Close $27.15    52 Week High $ 
Open $26.81    52 Week Low $ 
Day High $27.04    P/E N/A 
Day Low $26.39    EPS $ 
Volume 585,293